Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder Pain Syndrome Patients
Completed
- Conditions
- Bladder Pain Syndrome
- Interventions
- Procedure: Transurethral Coagulation (TUC)Procedure: Transurethral Resection(TUR)
- First Posted Date
- 2013-10-17
- Last Posted Date
- 2017-12-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 126
- Registration Number
- NCT01963988
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Effectiveness of the Combined WLI and Hyperthermia for GI Cancer Liver Metastasis
Not Applicable
Terminated
- Conditions
- Hyperthermia
- Interventions
- Radiation: Combined hyperthermia and radiation therapy
- First Posted Date
- 2013-10-16
- Last Posted Date
- 2020-03-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 11
- Registration Number
- NCT01963117
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Zydena on Cognitive Function of Alzheimer's Disease Patients
Phase 3
- Conditions
- Alzheimer's Disease
- Interventions
- Drug: Placebo + Donepezil 5mg or 10mgDrug: Zydena (Udenafil) 100mg + Donepezil 5mg or 10mgDrug: Zydena (Udenafil) 50mg + Donepezil 5mg or 10mg
- First Posted Date
- 2013-09-12
- Last Posted Date
- 2013-09-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 210
- Registration Number
- NCT01940952
- Locations
- 🇰🇷
Samguns Medical Center, Seoul, Korea, Republic of
Patients Who Refractory Cancer Conqueror for Bio New Drug Development Translational Research Establishment
- Conditions
- Refractory Cancer
- First Posted Date
- 2013-08-30
- Last Posted Date
- 2013-08-30
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1523
- Registration Number
- NCT01932047
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gyunggido, Korea, Republic of
A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell Lymphoma
Early Phase 1
Completed
- Conditions
- Histologically Proven Extranodal NKTcell Lymphoma
- Interventions
- First Posted Date
- 2013-07-31
- Last Posted Date
- 2013-07-31
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT01913119
- Locations
- 🇰🇷
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
🇰🇷Korea Cancer Center Hospital, Nowon-gu, Seoul, Korea, Republic of
🇰🇷Severance Hospital, Seodaemun-gu, Seoul, Korea, Republic of
Stereotactic Body Radiotherapy for Unresectable Hepatocellular Carcinoma
Not Applicable
Completed
- Conditions
- Localized Non-Resectable Adult Hepatocellular Carcinoma
- Interventions
- Radiation: Stereotactic body radiotherapy
- First Posted Date
- 2013-07-30
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 56
- Registration Number
- NCT01910909
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor Thrombosis
Phase 2
Completed
- Conditions
- Carcinoma. Hepatocellular
- Interventions
- Radiation: RT and hyperthermia after TACE
- First Posted Date
- 2013-07-30
- Last Posted Date
- 2016-08-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 69
- Registration Number
- NCT01911000
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A Gray Zone Approach to Stroke Volume Variation Derived From NICOM
Withdrawn
- Conditions
- Gray ZoneNeurological Diseases or ConditionsFluid ResponsivenessNon Invasive Cardiac Output Monitoring
- Interventions
- Other: 500ml fluid loading
- First Posted Date
- 2013-07-15
- Last Posted Date
- 2016-05-27
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT01898975
- Locations
- 🇰🇷
Samsung medical center, Seoul, Korea, Republic of
The Effect of Ligasure® to Destroy Cornual Portion of Fallopian Tube
Phase 3
Completed
- Conditions
- CompletedRecruiting
- Interventions
- Device: The Effect of Ligasure® to Destroy Cornual Portion of Fallopian Tube
- First Posted Date
- 2013-07-10
- Last Posted Date
- 2015-04-10
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT01894971
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy Study of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy for Bladder Pain Syndrome
Completed
- Conditions
- Pentosan PolysulfateBladder Pain SyndromeHydrodistension
- First Posted Date
- 2013-07-10
- Last Posted Date
- 2020-12-10
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 91
- Registration Number
- NCT01895153
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of